Mesa Laboratories Stock News

Brokerages expect Mesa Laboratories, Inc. (NASDAQ:MLAB) to report $34.50 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have issued estimates for Mesa L

Wall Street brokerages forecast that Mesa Laboratories, Inc. (NASDAQ:MLAB) will announce $2.03 earnings per share (EPS) for the current quarter, Zacks reports. Two analysts have provided estimates for

Panagora Asset Management Inc. acquired a new position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) in the 4th quarter, Holdings Channel reports. The fund acquired 375 shares of the medical inst

The "Sterilization Monitoring Market by End-user, Product, and Geography - Forecast and Analysis 2020-2024" report has been added to ResearchAndMarkets.com's offering.

Bank of Montreal Can grew its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 49.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The

Great West Life Assurance Co. Can purchased a new position in Mesa Laboratories, Inc. (NASDAQ:MLAB) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exch

Today we'll look at Mesa Laboratories, Inc. (NASDAQ:MLAB) and reflect on its potential as an investment. Specifically...

Citigroup Inc. grew its position in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 58.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 4,873 shar

Gyrolab Technology

UPPSALA, Sweden--(BUSINESS WIRE)--Gyros Protein Technologies AB, a Mesa Laboratories, Inc. (NASDAQ:MLAB) company, and pioneer in automated nanoliter-scale immunoassays and leading provider of peptide

Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) have earned an average recommendation of “Buy” from the six brokerages that are currently covering the firm, MarketBeat.com reports. One analyst has

Charles Schwab Investment Management Inc. lifted its position in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 3.4% during the 4th quarter, according to the company in its most recent disclosure with the S

Gary Owens became the CEO of Mesa Laboratories, Inc. (NASDAQ:MLAB) in 2017. This analysis aims first to contrast CEO...

Barclays PLC boosted its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 55.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commissi

Gary Owens has been the CEO of Mesa Laboratories, Inc. (NASDAQ:MLAB) since 2017. This analysis aims first to contrast...